Disease & Country disbursements amounts in USD
Global Fund Allocations 2014 - 2016 $14 B
Global Fund Donors

GFO Live

It's hard to imagine that it's been five years since the scandal that compromised Mauritania's HIV program and its relationship with the Global Fund, watching mobile teams canvass neighborhoods to promote HIV diagnostics testing and develop an accurate accounting of the number of cases of AIDS....
16 Jan 2015
The global strategy for fighting the spread and impact of TB is heavily supported by the Global Fund  through multiple grants to national TB and HIV programs. This can represent up to three quarters of funding for programs in high-burden countries.  A large proportion of those funds are used to buy...
15 Jan 2015
Reports on audits of grants in Rwanda and Ecuador were released by the Office of the Inspector General (OIG) at the end of December.
Rwanda
The audit of Rwanda's three grants concluded that risk management is generally effective across three areas: financial and fiduciary; health services and...
15 Jan 2015
The impact on upper-middle-income (UMI) countries of the decision to shift more resources to low-income countries remains the subject of heated and passionate discussions within the Global Fund ecology.

In several letters and briefs, civil society organizations (CSOs) have argued that the decision...
14 Jan 2015
Senegalese national Mouhamadou Diagne will take up his new role as the Global Fund's inspector general from March 2015, replacing the outgoing IG, Martin O'Malley, it was announced in late December.
Diagne has more than 20 years of experience in auditing and financial analysis, most recently as the...
13 Jan 2015

Aidspan is an international non-profit organization based in Kenya whose mission is to reinforce the effectiveness of the Global Fund to Fight AIDS, Tuberculosis and Malaria by serving as an independent watchdog of the Fund and its grant implementers

Examining the trends in costs of medicines for drug-susceptible and drug-resistant tuberculosis from 2010 - 2013; an analysis of Global Fund PQR data
15 Jan 2015

The paper examines the trends in costs of medicines to treat drug susceptible and drug-resistent tuberculosis. The trends include a comparison between the High Burden Countries, as categorized by WHO, and the other countries that all receive or have received Global Fund support.

Pages